· New pipeline expansion and platform technology upgrade

· MOU with Microsoft to upgrade TOFPOMICS^®

· Promote local/global technology transfer

· Nonclinical toxicology studies for OBX02-011 conducted

· Registered patents in USA, Australia, and Russia

· Joint research with SK chemicals and HK inno.N

· Selected as a Baby Unicorn200

· Development of 2nd generation platform technology

· Registration of two patents in 9 individual countries

· Established ONCOBIX

· Development of 1st generation platform technology

· Obtained Venture Company Certificate

· Research collaboration with Seoul Asan Medical Center